NCT06020898 - Sodium Valproate in Patients With Acute Ischemic Stroke | Biotech Hunter

Enrollment

40

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Sodium valproate

Patients with acute ischemic stroke included in the study are randomly assigned to low-dose sodium valproate group, high-dose sodium valproate group and placebo group. Besides receiving conventional treatment for stroke, 10mg/kg sodium valproate, 20mg/kg sodium valproate or normal saline were given intravenously for 3 consecutive days, respectively.

DRUG

Normal saline

Patients with acute ischemic stroke included in the study are randomly assigned to low-dose sodium valproate group, high-dose sodium valproate group and placebo group. Besides receiving conventional treatment for stroke, 10mg/kg sodium valproate, 20mg/kg sodium valproate or normal saline were given intravenously for 3 consecutive days, respectively.

Trial Locations (1)

200127

RECRUITING

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai